Certara(CERT)

Search documents
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
Newsfilter· 2024-04-09 20:15
PRINCETON, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. Certara also announced ...
Certara(CERT) - 2023 Q4 - Earnings Call Transcript
2024-03-01 02:33
Certara Inc. (NASDAQ:CERT) Q4 2023 Earnings Conference Call February 29, 2024 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO John Gallagher - CFO Conference Call Participants David Windley - Jefferies Luke Sergott - Barclays Jeff Garro - Stephens Michael Cherny - Leerink Partners Vikram Purohit - Morgan Stanley Max Smock - William Blair Operator Hello and thank you for standing by. Welcome to the Certara Fourth Quarter 2023 Earnings Conference Call. At this time, all participants ...
Certara, Inc. (CERT) Lags Q4 Earnings Estimates
Zacks Investment Research· 2024-03-01 00:06
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -18.18%. A quarter ago, it was expected that this company would post earnings of $0.11 per share when it actually produced earnings of $0.11, delivering no surprise.Over the last four quarters, the company has not be ...
Certara Reports Fourth Quarter 2023 Financial Results
Newsfilter· 2024-02-29 21:10
PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023. Fourth Quarter Highlights: Revenue was $88.0 million, compared to $86.6 million in the fourth quarter of 2022, representing growth of 2% over the fourth quarter of 2022.Strong sequential growth with record software bookings and broad-based recovery in technology enabled services bookings during the quarter.Net loss ...
Certara(CERT) - 2023 Q4 - Annual Report
2024-02-28 16:00
Table of Contents __________________________________ __________________________________ __________________________________ __________________________________ Title of each class Trading SymbolName of each exchange on which registered Common stock, par value $0.01 per share CERT The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended ...
Certara(CERT) - 2023 Q3 - Earnings Call Presentation
2023-11-09 16:04
1. As of 12/31/2022 Differentiated scientific and technology expertise Software Tech-driven Services © Copyright 2023 Certara, L.P. All rights reserved. PopPK Dose-response Renal impairment Hepatic impairment 5 6 Renal impairment Hepatic impairment Pediatric HIV Animal QT interval prolongation 3 PopPK Dose-response <2000 2000 - 2010 2011 - 2015 2016 - 2020 1. Science Direct search for publications by key search terms 2. Model‐Informed Drug Development: Current US Regulatory Practice and Future Consideration ...
Certara(CERT) - 2023 Q3 - Earnings Call Transcript
2023-11-09 03:41
Certara Inc. (NASDAQ:CERT) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants David Deuchler - Investor Relations William Feehery - Chief Executive Officer John Gallagher - Chief Financial Officer Conference Call Participants Jeff Garro - Stephens Inc David Windley - Jefferies Mike Ryskin - Bank of America Max Smock - William Blair Joe Vruwink - Baird Vikram Purohit - Morgan Stanley Operator Good day, and thank you for standing by. Welcome to the Certara Third Quarter 2023 Ea ...
Certara(CERT) - 2023 Q3 - Quarterly Report
2023-11-07 16:00
| --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------|-------|-----------|-------|----------------|--------------------|--------|-------|---------| | | | LEVEL 1 | | LEVEL2 \n(In | LEVEL \nthousands) | 3 | | TOTAL | | Assets | | | | | | | | | | Money market funds | $ | 145,552 | $ | — | $ | — | $ | 145,552 | | Interest rate swap assets | | — | | 9,344 | | — | | 9,344 | | Total assets | $ | 145,552 | $ | 9,344 | $ | — | $ | 154,896 | | | | | | | | | | | | Liabilities | | ...
Certara(CERT) - 2023 Q2 - Earnings Call Transcript
2023-08-10 02:50
Certara Inc. (NASDAQ:CERT) Q2 2023 Results Conference Call August 9, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO and Director John Gallagher - Chief Financial Officer Conference Call Participants David Windley - Jefferies Vikram Purohit - Morgan Stanley Jeff Garro - Stephens Inc Kyle Crews - Credit Suisse Financial Services Max Smock - William Blair Gaurav Goparaju - Berenberg Capital Markets Joe Vruwink - Baird Operator Good day, and thank you for standing by. Welcome to ...
Certara(CERT) - 2023 Q2 - Quarterly Report
2023-08-08 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 001-39799 ______________________ ...